analyst
AM
NASDAQ · AMGN
Amgen Inc.
Healthcare · Drug Manufacturers - General
$385.65
Up+$5.87 (+1.55%)
Updated Sep 20, 2026, 10:02 AM
SID Score
6.8/10
Composite research score
Smart Money
51/100
Neutral
- Market cap
- 209.24B
- P/E ratio
- 27.13
- Dividend yield
- 3.12%
- 52-week range
- $318.21 – $447.03
- Volume
- 8.53M
- Avg. volume
- 2.89M
Price performance
AMGN price history
1M range · 19 trading sessions · Daily adjusted prices
AMGN closed at $385.65 after 19 trading sessions, down 13.11% for the selected period.
- Last close
- $385.65
- Period change
- -13.11%
- Period low
- $375.65
- Period high
- $444.12
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | $378.51 | $386.50 | $378.51 | $385.65 | 8.53M |
| Sep 17, 2026 | $379.15 | $382.49 | $376.08 | $379.78 | 3.23M |
| Sep 16, 2026 | $377.01 | $379.11 | $374.46 | $376.35 | 2.4M |
| Sep 15, 2026 | $380.23 | $381.04 | $375.15 | $375.65 | 2.61M |
| Sep 14, 2026 | $381.94 | $384.61 | $376.76 | $381.50 | 2.71M |
| Sep 11, 2026 | $386.135 | $386.99 | $377.22 | $377.35 | 2.27M |
| Sep 10, 2026 | $387.84 | $391.666 | $381.51 | $382.47 | 3.43M |
| Sep 9, 2026 | $393.065 | $395.55 | $389.28 | $391.27 | 2.92M |
| Sep 8, 2026 | $408.90 | $410.025 | $391.17 | $393.17 | 6.83M |
| Sep 4, 2026 | $437.03 | $441.85 | $435.00 | $437.23 | 1.66M |
| Sep 3, 2026 | $445.67 | $445.815 | $438.0801 | $444.12 | 1.84M |
| Sep 2, 2026 | $440.65 | $445.57 | $435.00 | $442.84 | 2.29M |
| Sep 1, 2026 | $435.301 | $438.65 | $431.00 | $438.12 | 2.36M |
| Aug 31, 2026 | $428.59 | $431.85 | $426.00 | $429.88 | 2.34M |
| Aug 28, 2026 | $437.89 | $437.89 | $430.72 | $432.42 | 1.74M |
| Aug 27, 2026 | $433.08 | $442.13 | $431.01 | $436.99 | 1.76M |
| Aug 26, 2026 | $441.00 | $442.885 | $438.24 | $440.34 | 2.29M |
| Aug 25, 2026 | $443.26 | $447.03 | $441.26 | $442.24 | 2.1M |
| Aug 24, 2026 | $440.31 | $445.87 | $435.51 | $443.84 | 2.46M |
Latest AMGN news
The latest Smart Investors Daily articles mentioning AMGN.
Stock researchResearch & News · News
Loading stock research…